newsfilter
← Latest News
PR Newswire·

Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic...